Takeshi Yamashita

Author PubWeight™ 83.48‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Obesity paradox in Japanese patients after percutaneous coronary intervention: an observation cohort study. J Cardiol 2013 3.36
2 Urgent management of rapid heart rate in patients with atrial fibrillation/flutter and left ventricular dysfunction: comparison of the ultra-short-acting β1-selective blocker landiolol with digoxin (J-Land Study). Circ J 2013 1.87
3 Present status of anticoagulation treatment in Japanese patients with atrial fibrillation: a report from the J-RHYTHM Registry. Circ J 2011 1.75
4 Dabigatran in clinical practice for atrial fibrillation with special reference to activated partial thromboplastin time. Circ J 2012 1.66
5 Gender-specific relationship between serum uric acid level and atrial fibrillation prevalence. Circ J 2011 1.59
6 Optimal treatment strategy for patients with paroxysmal atrial fibrillation: J-RHYTHM Study. Circ J 2008 1.57
7 Incidence of ischemic stroke in Japanese patients with atrial fibrillation not receiving anticoagulation therapy--pooled analysis of the Shinken Database, J-RHYTHM Registry, and Fushimi AF Registry. Circ J 2014 1.49
8 Thromboembolic events in paroxysmal vs. permanent non-valvular atrial fibrillation. Subanalysis of the J-RHYTHM Registry. Circ J 2014 1.49
9 Validation of CHA₂DS₂-VASc and HAS-BLED scores in Japanese patients with nonvalvular atrial fibrillation: an analysis of the J-RHYTHM Registry. Circ J 2014 1.47
10 Time in the therapeutic range during warfarin therapy in Japanese patients with non-valvular atrial fibrillation. - A multicenter study of its status and infuential factors-. Circ J 2011 1.46
11 Target international normalized ratio values for preventing thromboembolic and hemorrhagic events in Japanese patients with non-valvular atrial fibrillation: results of the J-RHYTHM Registry. Circ J 2013 1.45
12 Use of Warfarin in Elderly Patients With Non-Valvular Atrial Fibrillation - Subanalysis of the J-RHYTHM Registry. Circ J 2015 1.45
13 Short-Term Safety and Plasma Concentrations of Edoxaban in Japanese Patients With Non-Valvular Atrial Fibrillation and Severe Renal Impairment. Circ J 2015 1.45
14 Relation between oscillatory breathing and cardiopulmonary function during exercise in cardiac patients. Circ J 2012 1.45
15 Progression to the persistent form in asymptomatic paroxysmal atrial fibrillation. Circ J 2014 1.44
16 Effects of Regional Differences in Asia on Efficacy and Safety of Edoxaban Compared With Warfarin - Insights From the ENGAGE AF-TIMI 48 Trial. Circ J 2015 1.44
17 Impact of early statin initiation on secondary prevention in Japanese patients with coronary artery disease. J Cardiol 2010 1.41
18 Validation of Risk Scoring System Excluding Female Sex From CHA2DS2-VASc in Japanese Patients With Nonvalvular Atrial Fibrillation – Subanalysis of the J-RHYTHM Registry. Circ J 2015 1.41
19 Target intensity of anticoagulation with warfarin in Japanese patients with valvular atrial fibrillation – subanalysis of the J-RHYTHM Registry. Circ J 2014 1.40
20 Electrocardiography characteristics of isolated non-compaction of ventricular myocardium in Japanese adult patients. Circ J 2010 1.39
21 Prevalence of atrial fibrillation in the general population of Japan: an analysis based on periodic health examination. Int J Cardiol 2008 1.24
22 Characteristics of congestive heart failure accompanied by atrial fibrillation with special reference to tachycardia-induced cardiomyopathy. Circ J 2007 1.22
23 Incidence of major bleeding complication of warfarin therapy in Japanese patients with atrial fibrillation. Circ J 2007 1.10
24 What are arrhythmogenic substrates in diabetic rat atria? J Cardiovasc Electrophysiol 2006 1.09
25 An in vivo study of a growth-factor enhanced, cell free, two-layered collagen-tricalcium phosphate in deep osteochondral defects. Biomaterials 2006 1.04
26 Progressive nature of paroxysmal atrial fibrillation. Observations from a 14-year follow-up study. Circ J 2004 1.03
27 Treatment strategy and clinical outcome in Japanese patients with atrial fibrillation. Heart Vessels 2009 1.03
28 AGEs-RAGE system mediates atrial structural remodeling in the diabetic rat. J Cardiovasc Electrophysiol 2008 1.02
29 Hangover susceptibility in relation to aldehyde dehydrogenase-2 genotype, alcohol flushing, and mean corpuscular volume in Japanese workers. Alcohol Clin Exp Res 2005 1.01
30 Brachial-ankle pulse wave velocity as a risk stratification index for the short-term prognosis of type 2 diabetic patients with coronary artery disease. Hypertens Res 2010 1.00
31 Effects of statin treatment in patients with coronary artery disease and chronic kidney disease. Heart Vessels 2013 0.97
32 Premature atrial complex with P'R prolongation indicates multiple atrioventricular nodal pathways. Circ J 2005 0.95
33 Long-term incidence and prognostic factors of the progression of new coronary lesions in Japanese coronary artery disease patients after percutaneous coronary intervention. Heart Vessels 2013 0.95
34 Subsequent vertebral fractures following spinal fusion surgery for degenerative lumbar disease: a mean ten-year follow-up. Spine (Phila Pa 1976) 2010 0.94
35 Prevalence and prognosis of patients with atrial fibrillation in Japan: a prospective cohort of Shinken Database 2004. Circ J 2008 0.94
36 Impact of aging on the clinical outcomes of Japanese patients with coronary artery disease after percutaneous coronary intervention. Heart Vessels 2013 0.93
37 Ischemic heart disease associated with bortezomib treatment combined with dexamethasone in a patient with multiple myeloma. Int J Hematol 2010 0.90
38 Facet joint orientation difference between cephalad and caudad portions: a possible cause of degenerative spondylolisthesis. Spine (Phila Pa 1976) 2009 0.89
39 J wave and ST segment elevation in the inferior leads: a latent type of variant Brugada syndrome? Jpn Heart J 2002 0.88
40 Associations between headache and stress, alcohol drinking, exercise, sleep, and comorbid health conditions in a Japanese population. J Headache Pain 2009 0.87
41 Associations of plasma C-reactive protein levels with the presence and extent of coronary stenosis in patients with stable coronary artery disease. Atherosclerosis 2005 0.87
42 Clinical characteristics and long-term clinical outcomes of Japanese heart failure patients with preserved versus reduced left ventricular ejection fraction: a prospective cohort of Shinken Database 2004-2011. J Cardiol 2013 0.87
43 Prevalence and the long-term prognosis of functional mitral regurgitation in Japanese patients with symptomatic heart failure. Heart Vessels 2013 0.85
44 A new scoring system for evaluating the risk of heart failure events in Japanese patients with atrial fibrillation. Am J Cardiol 2012 0.85
45 Effect of coffee intake on blood pressure in male habitual alcohol drinkers. Hypertens Res 2005 0.84
46 Echocardiographic predictors of frequency of paroxysmal atrial fibrillation (AF) and its progression to persistent AF in hypertensive patients with paroxysmal AF: results from the Japanese Rhythm Management Trial II for Atrial Fibrillation (J-RHYTHM II Study). Heart Rhythm 2011 0.84
47 Prevalence and prognosis of patients with heart failure in Tokyo: a prospective cohort of Shinken Database 2004-5. Int Heart J 2009 0.84
48 BCR signal through alpha 4 is involved in S6 kinase activation and required for B cell maturation including isotype switching and V region somatic hypermutation. Int Immunol 2002 0.83
49 T cell-specific gene targeting reveals that alpha4 is required for early T cell development. Eur J Immunol 2003 0.83
50 Investigation of optimal anticoagulation strategy for stroke prevention in Japanese patients with atrial fibrillation--the J-RHYTHM Registry study design. J Cardiol 2010 0.83
51 Beneficial Effect of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation - Results of the J-RHYTHM Registry 2. Circ J 2016 0.82
52 Clinical outcome after acute coronary syndrome in Japanese patients: an observational cohort study. J Cardiol 2009 0.82
53 Estimated glomerular filtration rate and proteinuria are associated with persistent form of atrial fibrillation: analysis in Japanese patients. J Cardiol 2012 0.82
54 Impact of reduced renal function on prognosis in Japanese patients with coronary artery disease: a prospective cohort of Shinken Database 2007. Hypertens Res 2009 0.81
55 lipopolysaccharide induces atrial arrhythmogenesis via down-regulation of L-type Ca2+ channel genes in rats. Int Heart J 2009 0.81
56 Stress distribution in the supraspinatus tendon after tendon repair: suture anchors versus transosseous suture fixation. Am J Sports Med 2007 0.81
57 Rate control and quality of life in patients with permanent atrial fibrillation: the Quality of Life and Atrial Fibrillation (QOLAF) Study. Circ J 2006 0.81
58 Evaluation of articular cartilage with 3D-SPGR MRI after autologous chondrocyte implantation. J Orthop Sci 2003 0.80
59 Antithrombotic therapy in atrial fibrillation: evaluation and positioning of new oral anticoagulant agents. Circ J 2011 0.80
60 Deficiency of testosterone associates with the substrate of atrial fibrillation in the rat model. J Cardiovasc Electrophysiol 2009 0.80
61 Body size and atrial fibrillation in Japanese outpatients. Circ J 2009 0.80
62 Nine-Year Trend of Anticoagulation Use, Thromboembolic Events, and Major Bleeding in Patients With Non-Valvular Atrial Fibrillation - Shinken Database Analysis. Circ J 2016 0.79
63 Incidence and predictors of rehospitalization of acute heart failure patients. Int Heart J 2015 0.79
64 Plasma vascular endothelial growth factor level is elevated in patients with multivessel coronary artery disease. Clin Cardiol 2004 0.79
65 Effect of combination therapy with the angiotensin receptor blocker losartan plus hydrochlorothiazide on brain perfusion in patients with both hypertension and cerebral hemodynamic impairment due to symptomatic chronic major cerebral artery steno-occlusive disease: a SPECT study. Cerebrovasc Dis 2012 0.79
66 Long-term safety and efficacy of sirolimus-eluting stents in Japanese patients: a single-center cohort study. J Invasive Cardiol 2009 0.79
67 Recent mortality of Japanese patients with atrial fibrillation in an urban city of Tokyo. J Cardiol 2011 0.78
68 Preoperative 123I-iomazenil SPECT imaging predicts cerebral hyperperfusion following endarterectomy for unilateral cervical internal carotid artery stenosis. Am J Nucl Med Mol Imaging 2011 0.78
69 Molecular and electrophysiological differences in the L-type Ca2+ channel of the atrium and ventricle of rat hearts. Circ J 2006 0.78
70 Impacts of patient characteristics on the effectiveness of landiolol in AF/AFL patients complicated with LV dysfunction: Subgroup analysis of the J-Land study. Adv Ther 2014 0.78
71 Synthesis of prostaglandin E(1) phosphate derivatives and their encapsulation in biodegradable nanoparticles. Pharm Res 2009 0.78
72 Role of cardiopulmonary dysfunction and left atrial remodeling in development of acute decompensated heart failure in chronic heart failure with preserved left ventricular ejection fraction. J Cardiol 2012 0.78
73 Mean corpuscular volume and the aldehyde dehydrogenase-2 genotype in male Japanese workers. Alcohol Clin Exp Res 2003 0.77
74 Usefulness of frequent supraventricular extrasystoles and a high CHADS2 score to predict first-time appearance of atrial fibrillation. Am J Cardiol 2013 0.77
75 Effects of smoking habit on the prevalence of atrial fibrillation in Japanese patients with special reference to sex differences. Circ J 2013 0.77
76 [Predictive value of cardiovascular events by high sensitivity CRP]. Nihon Rinsho 2002 0.77
77 Infiltration of macrophages through the atrial endocardium of inflammation-induced rats: contribution of fractalkine. Circ J 2009 0.77
78 Initial and programmed combination therapy with oral drugs for severe idiopathic pulmonary arterial hypertension. Int Heart J 2011 0.77
79 Angiotensin II type 1 receptor blocker attenuates diabetes-induced atrial structural remodeling. J Cardiol 2011 0.77
80 Molecular Mechanisms Underlying Urate-Induced Enhancement of Kv1.5 Channel Expression in HL-1 Atrial Myocytes. Circ J 2015 0.76
81 Nifekalant hydrochloride, a novel class III antiarrhythmic agent, suppressed postoperative recurrent ventricular tachycardia in a patient undergoing coronary artery bypass grafting and the Dor approach. Circ J 2003 0.76
82 Transpedicular hydroxyapatite grafting with indirect reduction for thoracolumbar burst fractures with neurological deficit: A prospective study. Indian J Orthop 2007 0.76
83 Recent characteristics and outcomes of Japanese stable angina pectoris after percutaneous coronary intervention. An observational cohort study using the Shinken Database. Int Heart J 2013 0.76
84 Role of arterial stiffness and impaired renal function in the progression of new coronary lesions after percutaneous coronary intervention. Cardiovasc Interv Ther 2012 0.76
85 Left Atrial Remodeling Assessed by Transthoracic Echocardiography Predicts Left Atrial Appendage Flow Velocity in Patients With Paroxysmal Atrial Fibrillation. Int Heart J 2016 0.76
86 No Additional Effect of DPP-4 Inhibitor on Preventing Atrial Fibrosis in Streptozotocin-Induced Diabetic Rat as Compared With Sulfonylurea. Int Heart J 2016 0.76
87 Development of congestive heart failure in Japanese patients with atrial fibrillation. Circ J 2007 0.75
88 [From the Point of View of Health Evaluation and Promotion (Ningen Dock) Facilities]. Rinsho Byori 2014 0.75
89 Heart failure with preserved versus reduced left ventricular systolic function: a prospective cohort of Shinken Database 2004-2005. J Cardiol 2009 0.75
90 Impact of drug alteration to maintain rhythm control in paroxysmal atrial fibrillation. - Subanalysis from J-RHYTHM study -. Circ J 2010 0.75
91 Non-traumatic Unilateral Intramuscular Hematoma in the Lower Leg. Intern Med 2016 0.75
92 Overshoot phenomena of respiratory gas variables during exercise recovery in cardiac patients. Circ J 2012 0.75
93 [Arrhythmia]. Nihon Rinsho 2009 0.75
94 Prognostic value of cardiopulmonary exercise testing in cardiac patients with atrial fibrillation. Int Heart J 2012 0.75
95 A marked increase in myeloblasts in the peripheral blood of a patient with Burkitt lymphoma following granulocyte colony-stimulating factor administration. Acta Haematol 2008 0.75
96 Pilsicainide-induced coronary vasospasm in a patient with Brugada-type electrocardiogram. Circ J 2005 0.75
97 [Stroke and atrial fibrillation]. Nihon Ronen Igakkai Zasshi 2003 0.75
98 Critical level of cerebral oxygenation during exercise in patients with left ventricular dysfunction. Circ J 2006 0.75
99 ABO Blood Type and Response of Activated Partial Thromboplastin Time to Dabigatran in Nonvalvular Atrial Fibrillation Patients. Circ J 2015 0.75
100 Basic echocardiographic features of patients with latent left ventricular outflow tract obstruction without left ventricular hypertrophy. Int Heart J 2012 0.75
101 [Management of atrial fibrillation associated with heart failure in the elderly]. Nihon Ronen Igakkai Zasshi 2006 0.75
102 Blood stasis secondary to heart failure forms warfarin-resistant left atrial thrombus. Int Heart J 2014 0.75
103 Site of the arrhythmogenic focus and cardiac vulnerability to ventricular fibrillation. Pacing Clin Electrophysiol 2002 0.75
104 Phytosterols dissolved in diacylglycerol oil reinforce the cholesterol-lowering effect of low-dose pravastatin treatment. Nutr Metab Cardiovasc Dis 2007 0.75
105 [Anticoagulation for the AF patients with ischemic heart disease]. Nihon Rinsho 2016 0.75
106 Successful treatment with total cranial irradiation for central nervous system involvement of Langerhans cell sarcoma during chemotherapy. Rinsho Ketsueki 2016 0.75
107 Relationship between 24-h Holter recordings and clinical outcomes in patients with permanent atrial fibrillation. J Cardiol 2012 0.75
108 [Clinical therapy for arrhythmias and EBM]. Nihon Naika Gakkai Zasshi 2006 0.75
109 Comparison of antiarrhythmics used in patients with paroxysmal atrial fibrillation: subanalysis of J-RHYTHM Study. Circ J 2009 0.75
110 Distribution of first-detected atrial fibrillation patients without structural heart diseases in symptom classifications. Circ J 2012 0.75
111 Regional Differences in Frequency of Warfarin Therapy and Thromboembolism in Japanese Patients With Non-Valvular Atrial Fibrillation - Analysis of the J-RHYTHM Registry. Circ J 2016 0.75
112 Unusual atrial response to electrical pacing during ischemia. J Electrocardiol 2002 0.75
113 Statin treatment for patients with paroxysmal atrial fibrillation. Int Heart J 2011 0.75
114 Rivaroxaban in clinical practice for atrial fibrillation with special reference to prothrombin time. Circ J 2014 0.75
115 Relation between variability of ventricular response intervals and exercise capacity in patients with non-valvular atrial fibrillation. Circ J 2004 0.75
116 [Programs for Continuing Medical Education: B session; 2. Non-vitamin K antagonist oral anticoagulants for atrial fibrillation]. Nihon Naika Gakkai Zasshi 2015 0.75
117 Study Design and Baseline Characteristics of the EXPAND Study: Evaluation of Effectiveness and Safety of Xa Inhibitor, Rivaroxaban for the Prevention of Stroke and Systemic Embolism in a Nationwide Cohort of Japanese Patients Diagnosed as Non-Valvular Atrial Fibrillation. Tohoku J Exp Med 2016 0.75
118 Ischemic events due to intraoperative microemboli developing in the cerebral hemisphere contralateral to carotid endarterectomy in a patient with preoperative cerebral hemodynamic impairment. Neurol Med Chir (Tokyo) 2012 0.75
119 A method for the simultaneous analysis of mRNA levels of multiple cardiac ion channels with a multi-probe RNase protection assay. Europace 2006 0.75
120 [Recent development of anticoagulation in stroke prevention for atrial fibrillation]. Nihon Rinsho 2014 0.75
121 Effect of cervical vagal nerve stimulation on defibrillation energy: a possible adjunct to efficient defibrillation. Jpn Heart J 2003 0.75
122 [Magnetic resonance imaging of repair cartilage]. Clin Calcium 2006 0.75
123 The susceptibility of lipoprotein(a) to copper oxidation is correlated with the susceptibility of autologous low density lipoprotein to oxidation. Clin Biochem 2003 0.75
124 Efficacy and effects on lipid metabolism of combination treatment with losartan + hydrochlorothiazide versus losartan + amlodipine: a 48-week prospective, multicenter, randomized, open-label trial. Clin Ther 2013 0.75
125 Impact of pulmonary vein isolation on left bundle branch block following tachycardia-induced cardiomyopathy in a patient with persistent atrial fibrillation. Intern Med 2012 0.75